Back to Overview
Martin Fabry PhD
Martin Fabry finished his bachelor’s degree in molecular biomedicine at the University of Bonn in 2014 and moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York, US) working on improving CRISPR/Cas9 technologies. Following completion of a master’s degree in life and medical sciences in 2016 with emphasis on molecular mechanisms of immunity, Martin started his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge studying genome organisation and stability.
After graduating with his doctorate degree in 2020, Martin worked as postdoctoral fellow in computational biology at the Gurdon Institute and European Bioinformatics Institute (EBI) in Cambridge with focus on stem cell development and establishing new technologies for stem cell differentiation.
Martin joined IP2 in 2018 as scientific consultant and started as a patent attorney candidate in late 2021.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
Nagoya Protocol 2.0
Additional New White Paper from IP2 concerning the Nagoya Protocol Our white paper "10 years of the Nagoya Protocol" from late 2023 explains the background, summarizes the current implementation into national law and provides an overview of the requirements that...
Penalty for the free-kick spray
In 2013, international soccer was enriched by a special curiosity: referees suddenly sprayed lines on the pitch with a kind of shaving foam to determine the correct distance of the kicker at a free kick. FIFA is said to have once promised Heine Vilarinho-Diaz (1), the...
EPO’s start-up offensive – not a big hit
It is a truism that newly founded, highly innovative companies are particularly dependent on the protection of their intellectual property, but often lack the budget to ensure this in a comprehensive manner. This is doubly fatal, as IP is usually the only asset that...
Back to Overview